Peptide Docket
Regulatory IntelligenceGet the brief
Home//Tirzepatide
Draft — not yet published. This page is part of the planned set but is set to noindex pending editorial expansion and clinical review. Facts below are limited to what we can source today; we do not publish prices, dosing, or sourcing.

Is Tirzepatide FDA approved?

Tirzepatide · FDA-approved medicine · brand-name product is the approved route.

Tirzepatide is a dual GIP/GLP-1 receptor agonist and an FDA-approved medicine (brands include Mounjaro and Zepbound).

Tirzepatide is FDA-approved and supported by large clinical trials for its approved indications.

Medical & editorial disclaimer. This article is independent reference information, not medical advice. Use any medicine only under the care of a licensed clinician. Peptide Docket is not affiliated with the FDA and does not sell medicines.